Informa Connect

Evaluate Key Areas of Compliance for Inspection Readiness, Navigate Regulatory Complexities and Discover Innovative Technologies and Solutions

The annual Compounding Pharmacy Compliance conference provides an in-depth look into key areas for compliance and proven strategies to strengthen compounding systems to ensure inspection readiness. As 2023 brought changes to USP regulations relevant to compounding, we hope you will find value in learning what these changes mean for compounding and inspections. These changes are meant to improve the quality of drugs for patients, and ensure safer conditions for compounders. Change often comes with challenges, and this event aims to help overcome the challenges and implement these changes seamlessly. A must-attend for all compounding professionals.

Key program features this year include 2 days of live content from 30+ industry thought leaders, live speaker Q&A, breakout discussions and on-demand content. Including perspectives from the US Pharmacopeia, FDA, Alliance for Pharmacy Compounding, Arizona State Board of Pharmacy, Wells Pharmacy Network, QuVa Pharma, Empower Pharmacy, Vios Compounding, Town & Country Compounding, Innovative Compounding Pharmacy, MedisourceRx, and more, this event is not to be missed.

Discuss Critical Topics Affecting the Ever-Evolving Drug Compounding Landscape:

• Relevant insight on the regulatory implications of recent USP Chapter revisions, particularly USP 797
• Tips on inspections and navigating FDA visits
• And more!

PLUS! Customize Your Learning Specific to Your Needs with Tracked Programming (Choose from A or B):

A. 503A Track

1. a. In-Depth Breakdown of Non-Sterile and Non-Hazardous Compounding Regulations
2. b. Navigating Drug Shortages, 503b Disruptions, and Vendor Qualifications
3. c. 503a Lab Testing, Quality Assurance and Risk Mitigation
4. d. Hospital Compounding: Challenges in Implementing USP 800 and NIOSH List

B. 503B Track

1. a. Navigating Drug Shortages and Challenges in Current Supply Chair
2. b. Comprehensive Insights into 503b Quality Control
3. c. Deep Dive on Regulatory Expectations for the Maturing 503b Industry
4. d. Implementation of a Recombinant Factor C Technology for Endotoxin Testing at a 503b Compounding Facility

C. And more!

For more details and to register you and your team, visit https://informaconnect.com/compounding-pharmacy-compliance/.